{
     "PMID": "21435875",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110719",
     "LR": "20161025",
     "IS": "1464-3405 (Electronic) 0960-894X (Linking)",
     "VI": "21",
     "IP": "8",
     "DP": "2011 Apr 15",
     "TI": "Proflavine derivatives as fluorescent imaging agents of amyloid deposits.",
     "PG": "2203-6",
     "LID": "10.1016/j.bmcl.2011.03.010 [doi]",
     "AB": "A series of proflavine derivatives for use to further image Abeta amyloid deposits were synthesized and characterized. Aged 3xTg-AD (23 months old) mice hippocampus sections incubated with these derivatives revealed preferential labeling of amyloid plaques. Furthermore an in vitro binding study showed an inhibitory effect, although moderate, of these compounds on Abeta(40) fibril formation. This study highlights the potential of proflavine as a molecular scaffold for designing new Abeta imaging agents, its native fluorescence allowing in vitro neuropathological staining in AD damaged brain sections.",
     "CI": [
          "Copyright (c) 2011 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Garin, Dominique",
          "Oukhatar, Fatima",
          "Mahon, Andrew B",
          "Try, Andrew C",
          "Dubois-Dauphin, Michel",
          "Laferla, Frank M",
          "Demeunynck, Martine",
          "Sallanon, Marcelle Moulin",
          "Chierici, Sabine"
     ],
     "AU": [
          "Garin D",
          "Oukhatar F",
          "Mahon AB",
          "Try AC",
          "Dubois-Dauphin M",
          "Laferla FM",
          "Demeunynck M",
          "Sallanon MM",
          "Chierici S"
     ],
     "AD": "INSERM, Unit U877, J Fourier University, La Tronche, France.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 AG021982/AG/NIA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20110306",
     "PL": "England",
     "TA": "Bioorg Med Chem Lett",
     "JT": "Bioorganic & medicinal chemistry letters",
     "JID": "9107377",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Fluorescent Dyes)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (1-40))",
          "CY3RNB3K4T (Proflavine)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/pathology",
          "Amyloid beta-Peptides/antagonists & inhibitors/metabolism",
          "Animals",
          "Disease Models, Animal",
          "Fluorescent Dyes/*chemistry",
          "Mice",
          "Mice, Transgenic",
          "Microscopy, Fluorescence",
          "Peptide Fragments/antagonists & inhibitors/metabolism",
          "Plaque, Amyloid/*pathology",
          "Proflavine/chemical synthesis/*chemistry"
     ],
     "EDAT": "2011/03/26 06:00",
     "MHDA": "2011/07/20 06:00",
     "CRDT": [
          "2011/03/26 06:00"
     ],
     "PHST": [
          "2011/02/03 00:00 [received]",
          "2011/03/01 00:00 [revised]",
          "2011/03/02 00:00 [accepted]",
          "2011/03/26 06:00 [entrez]",
          "2011/03/26 06:00 [pubmed]",
          "2011/07/20 06:00 [medline]"
     ],
     "AID": [
          "S0960-894X(11)00321-0 [pii]",
          "10.1016/j.bmcl.2011.03.010 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Bioorg Med Chem Lett. 2011 Apr 15;21(8):2203-6. doi: 10.1016/j.bmcl.2011.03.010. Epub 2011 Mar 6.",
     "term": "hippocampus"
}